Discovery Stems From Here
Find your tools for building human cell-based models & screening assays
NEW Human iPSC-Derived Astrocytes (ax0665) available now
Axol uses human iPSCs to generate specific cell types
We do NOT use animal cells or embryonic stem cells (ESCs)
Welcome to Axol Bioscience
YOUR HUMAN CELL CULTURE SPECIALISTS
We provide highly validated human iPSC-derived cells and primary cells from healthy donors and patients of specific disease backgrounds, together with optimized media and growth supplements. Axol aims to develop the best human cell biology research tools to advance medical research and drug discovery. Combining our passion for science with quality, innovation and customer service, we deliver robust and reliable products that our customers need to advance their research faster.
Chief Operating Officer appointed at Axol Bioscience15 May 2019
We are delighted to announce that Chris Kirton joins us as our Chief Operating Officer; a senior operations leader with over 15 years of drug development, commercial and operational management experience in both industry and academia. Chris joins us from a leading supplier in the biotech industry and takes up his leadership role at Axol, bringing with him his extensive operational experience at the highest levels, focusing Axol's position and supporting growth within the Human iPSC-Derived Stem Cell market.
Major success for MESO-BRAIN partners will lead to breakthrough technology for developing new brain models2 May 2019
Neuroimmunology Drug Development (NIDD) 201927 March 2019
Axol Bioscience launch human iPSC-derived Microglia13 December 2018
Cambridge, UK – (6th December 2018) – Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.
Good Cell Culture Practice in Toxicology Seminar16 October 2018
Axol Bioscience is presenting at the two-day seminar hold by Evercyte and Altetox in Vienna, from 30-31 October. Book your ticket today.